Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02790723 · ClinicalTrials.gov registry record · Phase 1
Safety of Intra-Articular Sc-rAAV2.5IL-1Ra in Subjects With Moderate Knee OA
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT02790723: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT02790723 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02790723, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study seeks to determine the safety of three different doses of sc-rAAV2.5IL-1Ra delivered by intra-articular injection into one knee joint of patients with moderate OA of the knee.
Interventions
- DRUG sc-rAAV2.5IL-1Ra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2022-03-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02790723
The ClinicalTrials.gov registry entry for NCT02790723 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sc-rAAV2.5IL-1Ra is the first listed.
NCT02790723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02790723 about?
NCT02790723 is a clinical study titled "Safety of Intra-Articular Sc-rAAV2.5IL-1Ra in Subjects With Moderate Knee OA". This study seeks to determine the safety of three different doses of sc-rAAV2.5IL-1Ra delivered by intra-articular injection into one knee joint of patients with moderate OA of the knee.
What is the current status of trial NCT02790723?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2019-06-05. Estimated completion is 2022-03-17.
What interventions are being tested in trial NCT02790723?
The interventions under investigation include: sc-rAAV2.5IL-1Ra (DRUG).
Who is sponsoring clinical trial NCT02790723?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.